v3.26.1
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)
6 Months Ended
Jul. 23, 2022
Jul. 12, 2022
Sep. 27, 2021
Sep. 27, 2021
Sep. 23, 2021
Jun. 30, 2026
Dec. 31, 2025
Sep. 17, 2021
Loss Contingencies [Line Items]                
Proceeds from sale of stock     $ 116,150,000   $ 116,150,000      
Cash and noncash consideration rate   1.00%            
Percentage of aggregate sales price of securities sold 5.00%              
Deferred underwriting commissions           $ 4,025,000 $ 4,025,000 $ 4,025,000
Aggregrate 3% [Member]                
Loss Contingencies [Line Items]                
Aggregrate value $ 100,000,000              
Aggregrate 2% [Member] | Minimum [Member]                
Loss Contingencies [Line Items]                
Aggregrate value 100,000,000              
Aggregrate 2% [Member] | Maximum [Member]                
Loss Contingencies [Line Items]                
Aggregrate value 200,000,000              
Aggregrate 1% [Member]                
Loss Contingencies [Line Items]                
Aggregrate value 200,000,000              
Chardan [Member]                
Loss Contingencies [Line Items]                
Management fee $ 800,000              
Percentage of aggregate value of initial public combination 1.00%              
Chardan [Member] | Maximum [Member]                
Loss Contingencies [Line Items]                
Aggregrate reimbursable out of pocket expenses           $ 150,000    
Over-Allotment Option [Member]                
Loss Contingencies [Line Items]                
Sale private placement warrants         11,500,000      
Underwriting discount           $ 0.20    
Sale of stock, consideration received on transaction         $ 115,000,000 $ 2,300,000    
Offering expenses           $ 100,000    
Public or Private Securities [Member]                
Loss Contingencies [Line Items]                
Percentage of aggregate sales price of securities sold 1.00%              
Underwriters [Member]                
Loss Contingencies [Line Items]                
Shares for future issuance           1,500,000    
Underwriters [Member] | Over-Allotment Option [Member]                
Loss Contingencies [Line Items]                
Sale private placement warrants         1,500,000      
Proceeds from sale of stock       $ 15,000,000